GMED Clase A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026GMED Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
GMED Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Globus Medical, Inc. Class A Common Stock Descripción general de la empresa de Wikipedia
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | GMED | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 19.4promedio 5A ≈54.5 | ≈54.5 | 28.6 | Infravalorado | |
| PEG Ratio (Ratio PEG) | ≈0.6 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | GMED | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 20.3%promedio 5A ≈12.3% | ≈12.3% | 13.1% | De primer nivel | |
| Margen EBITDA (TTM) | 29.2%promedio 5A ≈21.3% | ≈21.3% | 13.7% | De primer nivel | |
| Margen antes de impuestos (TTM) | 21.0%promedio 5A ≈13.7% | ≈13.7% | 11.8% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 17.0%promedio 5A ≈11.4% | ≈11.4% | 9.0% | De primer nivel | |
| ROA (TTM) | 10.2%promedio 5A ≈6.0% | ≈6.0% | 4.6% | De primer nivel | |
| ROE (TTM) | 11.8%promedio 5A ≈6.6% | ≈6.6% | 8.9% | De primer nivel | |
| ROIC | 9.3%promedio 5A ≈5.8% | ≈5.8% | 7.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | GMED | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 4.6promedio 5A ≈4.5 | ≈4.5 | 2.4 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 2.7promedio 5A ≈1.9 | ≈1.9 | 1.0 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | GMED | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 16.7%promedio 5A ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 42.2%promedio 5A ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 30.1% | · | · | · | |
| EPS YoY (EPS interanual) | 422.7%promedio 5A ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | 422.3%promedio 5A ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | 28.4%promedio 5A ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | 31.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | 41.4%promedio 5A ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | 39.4% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | GMED | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.6promedio 5A ≈0.5 | ≈0.5 | 0.5 | En línea | |
| Inventory Turnover (Rotación de Inventario) | 1.4promedio 5A ≈1.2 | ≈1.2 | 1.8 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 4.8promedio 5A ≈5.0 | ≈5.0 | 6.2 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$489.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 5, 2026 | $1.34 | $1.12 | 19.5% |
| 31 de marzo de 2026 | May 12, 2026 | $1.12 | $0.94 | 19.4% |
| 31 de diciembre de 2025 | $1.28 | $1.17 | 9.2% | |
| 30 de septiembre de 2025 | $1.18 | $0.80 | 47.8% | |
| 30 de junio de 2025 | $0.86 | $0.77 | 11.6% | |
| 31 de marzo de 2025 | $0.68 | $0.76 | -10.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| Margen Bruto % | · | · | 65.0% | · | 75.0% |
| Margen Operativo % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| Beneficio neto | $538M | $103M | $123M | $190M | $149M |
| EPS Diluido | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 4.3 | 2.5 | 4.9 | · | 6.2 |
| Ratio Rápido | 2.5 | 0.8 | 1.4 | · | 3.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $589M | $405M | $165M | · | $219M |
Propietarios institucionales (13F) 639 declarantes · $10.4B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 76 (-42 vs trimestre anterior) | 82 (+32 vs trimestre anterior) | 254 (+26 vs trimestre anterior) | 180 (0 vs trimestre anterior) | +5.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921 072 916 | 10 549 455 | 8,82% | Acciones |
| BlackRock, Inc. | $853 839 261 | 10 806 724 | 8,18% | Acciones |
| JANUS HENDERSON GROUP PLC | $656 831 032 | 7 623 095 | 6,29% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $403 546 103 | 5 107 532 | 3,86% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394 606 359 | 4 994 385 | 3,78% | Acciones |
| Invesco Ltd. | $340 515 006 | 4 309 771 | 3,26% | Acciones |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338 141 467 | 4 279 730 | 3,24% | Acciones |
| STATE STREET CORP | $293 540 630 | 3 714 029 | 2,81% | Acciones |
| Sculptor Capital LP | $237 030 000 | 3 000 000 | 2,27% | Acciones |
| JPMORGAN CHASE & CO | $230 761 440 | 2 743 850 | 2,21% | Acciones |
| Burgundy Asset Management Ltd. | $212 054 428 | 3 460 983 | 2,03% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $205 090 439 | 2 380 344 | 1,96% | Acciones |
| BANK OF MONTREAL /CAN/ | $191 638 042 | 2 425 491 | 1,83% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $187 250 224 | 2 369 310 | 1,79% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $170 151 584 | 2 153 014 | 1,63% | Acciones |
| GOLDMAN SACHS GROUP INC | $140 764 853 | 1 781 608 | 1,35% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135 630 225 | 1 716 621 | 1,30% | Acciones |
| Boston Trust Walden Corp | $124 311 253 | 1 573 361 | 1,19% | Acciones |
| Boston Partners | $122 847 510 | 1 554 990 | 1,18% | Acciones |
| Allspring Global Investments Holdings, LLC | $119 384 889 | 1 571 681 | 1,14% | Acciones |
| GENEVA CAPITAL MANAGEMENT LLC | $111 962 440 | 1 417 067 | 1,07% | Acciones |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101 519 633 | 1 284 896 | 0,97% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98 471 901 | 1 246 322 | 0,94% | Acciones |
| Quantinno Capital Management LP | $96 320 933 | 1 219 098 | 0,92% | Acciones |
| NORGES BANK | $89 048 300 | 1 127 051 | 0,85% | Acciones |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88 055 393 | 1 114 484 | 0,84% | Acciones |
| MORGAN STANLEY | $86 496 544 | 1 094 753 | 0,83% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84 736 329 | 1 072 476 | 0,81% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81 207 111 | 1 027 808 | 0,78% | Acciones |
| WELLS FARGO & COMPANY/MN | $78 742 680 | 996 617 | 0,75% | Acciones |
| Madison Avenue Partners, LP | $73 891 416 | 935 216 | 0,71% | Acciones |
| ANTIPODES PARTNERS Ltd | $71 581 796 | 905 984 | 0,69% | Acciones |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70 042 286 | 886 499 | 0,67% | Acciones |
| NORTHERN TRUST CORP | $69 578 813 | 880 633 | 0,67% | Acciones |
| AXA Investment Managers S.A. | $68 885 959 | 1 202 828 | 0,66% | Acciones |
| Global Alpha Capital Management Ltd. | $67 681 230 | 856 616 | 0,65% | Acciones |
| Vestal Point Capital, LP | $67 158 500 | 850 000 | 0,64% | Acciones |
| UBS Group AG | $65 909 432 | 834 191 | 0,63% | Acciones |
| Bank of New York Mellon Corp | $61 258 598 | 775 328 | 0,59% | Acciones |
| FMR LLC | $60 683 705 | 768 051 | 0,58% | Acciones |
| BANK OF AMERICA CORP /DE/ | $58 239 298 | 737 113 | 0,56% | Acciones |
| Stephens Investment Management Group LLC | $57 159 864 | 723 451 | 0,55% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $56 575 822 | 716 059 | 0,54% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $54 970 813 | 695 745 | 0,53% | Acciones |
| Clark Capital Management Group, Inc. | $54 271 890 | 686 899 | 0,52% | Acciones |
| AMERICAN CAPITAL MANAGEMENT INC | $51 599 219 | 653 072 | 0,49% | Acciones |
| ANCHOR CAPITAL ADVISORS LLC | $51 225 201 | 648 338 | 0,49% | Acciones |
| Camber Capital Management LP | $47 216 000 | 800 000 | 0,45% | Acciones |
| Capital World Investors | $46 664 254 | 590 612 | 0,45% | Acciones |
| Artemis Investment Management LLP | $45 305 914 | 573 420 | 0,43% | Acciones |
Informantes de la empresa 22 insiders · 11 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 21 de enero de 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 23 de enero de 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 27 de enero de 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 21 de enero de 2026 A | 0 | 0 | 2 | $-2 032 133 |
| Richard A Baron | Senior VP and CFO | 2 de mayo de 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 7 de marzo de 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 25 de febrero de 2026 M | 0 | 0 | 3 | $-3 441 700 |
| David C Paul | Executive Chairman | 21 de enero de 2026 A | 60 417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 1 de febrero de 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 25 de junio de 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2 de febrero de 2018 A | 35 217 | 0 | 0 | $0 |
| James R Tobin | Consejero | 15 de septiembre de 2026 M | 0 | 0 | 1 | $-2 237 400 |
| Stephen T Zarrilli | Consejero | 18 de agosto de 2026 M | 0 | 0 | 2 | $-4 283 250 |
| David D Davidar | Consejero | 27 de julio de 2026 G | 507 675 | 0 | 2 | $-4 169 000 |
| Ann D Rhoads | Consejero | 4 de junio de 2026 M | 40 384 | 0 | 2 | $-818 000 |
| Dan Wolterman | Consejero | 21 de enero de 2026 A | 24 025 | 0 | 0 | $0 |
| Leslie V Norwalk | Consejero | 21 de enero de 2026 A | 10 419 | 0 | 2 | $-557 600 |
| Dan Lemaitre | Consejero | 21 de enero de 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | Consejero | 21 de enero de 2026 A | 15 578 | 0 | 0 | $0 |
| Robert Andrew Douglas | Consejero | 21 de enero de 2026 A | 2 005 | 0 | 0 | $0 |
| Kurt Wheeler | Consejero | 22 de enero de 2019 A | 44 319 | 0 | 0 | $0 |
| Robert Liptak | Consejero | 22 de enero de 2019 A | 26 159 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 69 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,90% | 16 797 NS | 31 de julio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,26% | 300 351 NS | 31 de julio de 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,83% | 122 008 SH | 2 de octubre de 2026 | Diario |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,52% | 13 339 NS | 31 de julio de 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,37% | 22 796 NS | 31 de julio de 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 340 460 NS | 31 de julio de 2026 | N-PORT |
| IHI · iShares Trust | 1,25% | 541 723 SH | 11 de septiembre de 2026 | Diario |
| RFG · Invesco Exchange-Traded Fund Trust | 0,81% | 36 501 SH | 2 de octubre de 2026 | Diario |
| MCOW · Pacer Funds Trust | 0,68% | 92 NS | 31 de julio de 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,58% | 9 542 NS | 31 de julio de 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,50% | 13 493 SH | 2 de octubre de 2026 | Diario |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,47% | 111 810 SH | 19 de agosto de 2026 | Diario |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 20 104 NS | 31 de julio de 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,32% | 23 234 NS | 31 de julio de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,30% | 16 476 SH | 2 de octubre de 2026 | Diario |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,29% | 16 839 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,28% | 35 968 SH | 11 de septiembre de 2026 | Diario |
| BKMC · BNY Mellon ETF Trust | 0,27% | 22 533 NS | 31 de julio de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,25% | 12 456 NS | 31 de julio de 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 183 180 SH | 19 de agosto de 2026 | Diario |
| VBK · VANGUARD INDEX FUNDS | 0,24% | 1 499 816 SH | 19 de agosto de 2026 | Diario |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 49 674 NS | 31 de julio de 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,19% | 1 664 NS | 31 de julio de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 57 770 NS | 31 de julio de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,15% | 284 148 NS | 31 de julio de 2026 | N-PORT |
| IYH · iShares Trust | 0,13% | 65 761 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,13% | 338 547 SH | 19 de agosto de 2026 | Diario |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,13% | 22 085 SH | 2 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 53 700 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,13% | 245 718 NS | 31 de julio de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,12% | 39 173 NS | 31 de julio de 2026 | N-PORT |
| SMMD · iShares Trust | 0,11% | 59 918 SH | 11 de septiembre de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,11% | 2 596 850 SH | 19 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,10% | 1 300 059 SH | 19 de agosto de 2026 | Diario |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 8 946 SH | 19 de agosto de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,10% | 103 731 NS | 31 de julio de 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,10% | 10 513 NS | 31 de julio de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 10 277 SH | 2 de octubre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 6 977 NS | 31 de julio de 2026 | N-PORT |
| IWS · iShares Trust | 0,08% | 166 482 SH | 11 de septiembre de 2026 | Diario |
| WSML · iShares Trust | 0,08% | 6 832 SH | 11 de septiembre de 2026 | Diario |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 13 036 NS | 31 de julio de 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 458 676 SH | 11 de septiembre de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,04% | 87 854 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 2 717 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 205 429 NS | 31 de julio de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 20 026 SH | 2 de octubre de 2026 | Diario |
| DFSU · Dimensional ETF Trust | 0,03% | 8 925 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 11 916 NS | 31 de julio de 2026 | N-PORT |
| IUSG · iShares Trust | 0,02% | 99 439 SH | 11 de septiembre de 2026 | Diario |
| IWD · iShares Trust | 0,02% | 248 750 SH | 11 de septiembre de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 67 710 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,02% | 25 284 SH | 19 de agosto de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,02% | 27 167 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 38 185 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3 476 NS | 31 de julio de 2026 | N-PORT |
| IYY · iShares Trust | 0,01% | 4 949 SH | 11 de septiembre de 2026 | Diario |
| IWB · iShares Trust | 0,01% | 77 825 SH | 11 de septiembre de 2026 | Diario |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 15 270 SH | 2 de octubre de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 145 193 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,01% | 30 738 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3 596 212 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89 702 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 18 804 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9 508 SH | 19 de agosto de 2026 | Diario |
| IJH · iShares Trust | · | 3 976 473 SH | 11 de septiembre de 2026 | Diario |
| IJK · iShares Trust | · | 657 157 SH | 11 de septiembre de 2026 | Diario |
| XJH · iShares Trust | · | 15 479 SH | 8 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 5 094 SH | 11 de septiembre de 2026 | Diario |
GMED Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
13 analistas · 2026-10-03Objetivo medio $100.92 +33,5%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.